Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Assessment of Nutrition & Dietary Intervention in Hypermobile Ehlers Danlos Syndrome (hEDS/HSD): a Personalised Approach: Phase 2 & 3

NCT05148039 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT05148039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05148039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Assessment of Nutrition & Dietary Intervention in Hypermobile Ehlers Danlos Syndrome (hEDS/HSD): a Personalised Approach: Phase 2 & 3
Lead sponsor
Queen Mary University of London
Phase
Not applicable
Overall status
Completed
Start date
April 7, 2022
Completion date
July 3, 2023
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

functional gastrointestinal disorders, hypermobile ehlers-danlos syndrome, irritable bowel syndrome